It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | ActiveSreetech Pharma (India) Private Limited, a active private limited company, was established on 30 September 2010 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100TG2010PTC070650. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Aruna Kumari Achanta (Director), Kasi Viswanath Arigela (Director). Past directors included Srinivasa Rao Kola, Dhanalaxmi Dara. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat # 401, Durga Residency,Opp. Kennedy School, Mytri Nagar,Kukatpally, Hyderabad, Telangana, 500072.
U24100TG2010PTC070650
070650
30 September 2010
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sreetech Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aruna Kumari Achanta | Director | 30 Sep 2010 | Current |
| Kasi Viswanath Arigela | Director | 20 Nov 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jun 2012 | Past |
| Pramod Abcsdd | Director | 08 Jun 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sreetech Pharma (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.84% decrease. The company also saw a substantial improvement in profitability, with a 601.22% increase in profit. The company's net worth Soared by an impressive increase of 38.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Sreetech Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sreetech Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sreetech Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreetech Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sreetech Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Sreetech Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
Progress on Kasi Viswanath Arigela was appointed as a Director was appointed as a Director on 20 Nov 2010 & has been associated with this company since 15 years 1 month . was documented.
The activity Aruna Kumari Achanta was appointed as a Director was appointed as a Director on 30 Sep 2010 & has been associated with this company since 15 years 2 months . was completed.
Sreetech Pharma (India) Private Limited was registered on 30 Sep 2010 with Roc Hyderabad & aged 15 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Sreetech Pharma (India) Private Limited is U24100TG2010PTC070650.
Sreetech Pharma (India) Private Limited is headquartered at Flat # 401, Durga Residency,Opp. Kennedy School, Mytri Nagar,Kukatpally, Hyderabad, Telangana, 500072.
Sreetech Pharma (India) Private Limited was incorporated on 30 September 2010.
The current directors of Sreetech Pharma (India) Private Limited are
The primary industry of Sreetech Pharma (India) Private Limited is Pharma.
Sreetech Pharma (India) Private Limited is unlisted.
The authorized capital of Sreetech Pharma (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Sreetech Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX